Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis.
about
Methotrexate for topical application in an extemporaneous preparation.Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells.Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasisAssessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritisLong-term study of the impact of methotrexate on serum cytokines and lymphocyte subsets in patients with active rheumatoid arthritis: correlation with pharmacokinetic measuresInvolvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics.Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study.Pharmacokinetic consideration of synthetic DMARDs in rheumatoid arthritis.Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexate.Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers.Variability of oral bioavailability for low dose methotrexate in rats.Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats.Role of intestinal efflux transporters in the intestinal absorption of methotrexate in rats.
P2860
Q30316265-B0D39708-623A-4B99-82A2-52DF9E3F597CQ35471696-61E3E54D-7152-4271-B94A-01A56781CBF2Q35803952-5421CFB6-B708-4A63-B617-38390B2C89ECQ36462243-67566519-5AD0-4466-8DFE-2EECF1DD207FQ37019144-28EB802A-3A22-465F-8326-DC12AFF2B74DQ37148784-B078A119-541C-496E-A7E5-8A327BAF4829Q37587400-8DF996F3-16AD-4DA6-83B8-C69136E39562Q38097969-FC04A4D5-313B-4E34-BC80-AC709A3F0B55Q38663357-9A915D0A-EC8B-48B7-9784-FBFD6EE98359Q38991972-89EDBFE1-213C-4E0E-9E94-CC7691D02663Q43865018-4C2BFB51-6210-4FBE-95B9-8D72E243071BQ45934051-7E944E2E-A631-44FE-B065-633BA66EE00DQ46990256-42C6D301-94CF-42B2-BC5B-3AB0DF7AE98A
P2860
Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Intraindividual variability of ...... ation in rheumatoid arthritis.
@ast
Intraindividual variability of ...... ation in rheumatoid arthritis.
@en
Intraindividual variability of ...... ation in rheumatoid arthritis.
@nl
type
label
Intraindividual variability of ...... ation in rheumatoid arthritis.
@ast
Intraindividual variability of ...... ation in rheumatoid arthritis.
@en
Intraindividual variability of ...... ation in rheumatoid arthritis.
@nl
prefLabel
Intraindividual variability of ...... ation in rheumatoid arthritis.
@ast
Intraindividual variability of ...... ation in rheumatoid arthritis.
@en
Intraindividual variability of ...... ation in rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
Intraindividual variability of ...... ation in rheumatoid arthritis.
@en
P2093
P2860
P304
P356
10.1136/ARD.53.7.475
P407
P577
1994-07-01T00:00:00Z